Vectura Appoints Chief Commercial Officer

Mark Bridgewater will focus on helping the company transform into a contract development and manufacturing organization.

By: Kristin Brooks

Managing Editor, Contract Pharma

Vectura Group plc has appointed Mark Bridgewater as Chief Commercial Officer, a newly-created role focused on helping the company transform into a contract development and manufacturing organization (CDMO). In his new position, Mr. Bridgewater will implement strong sales processes in order to secure new business, as well as building out a commercial team and driving Vectura’s brand market presence.
 


Mr. Bridgewater has more than 20 years of experience in medical device and pharmaceutical services. Mr. Bridgewater previously served as vice president of business development and account management for Europe and Asia at Flex, a global design, engineering and manufacturing organization. Prior to that, he was vice president of Global Business Development, Advanced Delivery Technologies at Catalent.



Will Downie, CEO of Vectura, said, “I am thrilled to have Mark join Vectura, where he will play a pivotal role in driving the future growth of the organization. He comes to the company with an impressive track record of delivering sustained growth and market success in each of his previous roles. His versatile leadership skills and growth mindset will help accelerate the transformation of the company into a true leader in the outsourcing space.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters